300937 药易购
已收盘 06-26 15:00:00
资讯
新帖
简况
股市必读:药易购(300937)5月15日董秘有最新回复
证券之星 · 05-18
股市必读:药易购(300937)5月15日董秘有最新回复
药易购:公司不存在被实施其他风险警示(ST)的情形
证券之星 · 05-15
药易购:公司不存在被实施其他风险警示(ST)的情形
药易购:以全渠道供应链为核心,以数智创新技术为驱动
证券之星 · 05-15
药易购:以全渠道供应链为核心,以数智创新技术为驱动
药易购:公司始终将合规运营放在首位
证券日报 · 02-09
药易购:公司始终将合规运营放在首位
药易购再向优秀员工授出7台阿维塔汽车 强化人才激励共谋长远发展
市场资讯 · 02-06
药易购再向优秀员工授出7台阿维塔汽车 强化人才激励共谋长远发展
药易购2025年业绩预降超七成,受市场环境及所得税政策调整等多重因素影响
中金财经 · 01-30
药易购2025年业绩预降超七成,受市场环境及所得税政策调整等多重因素影响
药易购:公司将依据案件执行情况按会计准则进行会计处理
证券之星 · 01-27
药易购:公司将依据案件执行情况按会计准则进行会计处理
药易购:设立全资子公司赋能AI医疗全场景
证券之星 · 01-16
药易购:设立全资子公司赋能AI医疗全场景
股市必读:药易购(300937)1月15日收盘跌11.79%,主力净流入397.58万元
证券之星 · 01-16
股市必读:药易购(300937)1月15日收盘跌11.79%,主力净流入397.58万元
药易购:设立蜀坦人工智能并完成DeepSeek本地化部署
证券之星 · 01-15
药易购:设立蜀坦人工智能并完成DeepSeek本地化部署
股市必读:药易购(300937)1月9日董秘有最新回复
证券之星 · 01-12
股市必读:药易购(300937)1月9日董秘有最新回复
流感疫情持续,防控系统工程再受考验
证券之星 · 2025-12-31
流感疫情持续,防控系统工程再受考验
药易购:公司已将符合条件的数据产品识别为无形资产并进行初始计量
证券之星 · 2025-02-28
药易购:公司已将符合条件的数据产品识别为无形资产并进行初始计量
医药商业板块盘中走弱,药易购领跌6.61%
金融界 · 2025-02-11
医药商业板块盘中走弱,药易购领跌6.61%
异动快报:药易购(300937)2月10日11点11分触及涨停板
证券之星 · 2025-02-10
异动快报:药易购(300937)2月10日11点11分触及涨停板
合纵药易购申请基于商品装箱的智能控制方法专利,便于引入可推荐商品并符合用户购买习惯
金融界 · 2025-01-31
合纵药易购申请基于商品装箱的智能控制方法专利,便于引入可推荐商品并符合用户购买习惯
药易购(300937.SZ)发预减,预计年度净利润1450万元-1950万元,同比下降67.24%-75.64%
智通财经 · 2025-01-20
药易购(300937.SZ)发预减,预计年度净利润1450万元-1950万元,同比下降67.24%-75.64%
药易购:预计2024年全年归属净利润盈利1450万元至1950万元
证券之星 · 2025-01-20
药易购:预计2024年全年归属净利润盈利1450万元至1950万元
药易购新提交2件商标注册申请
证券之星 · 2025-01-12
药易购新提交2件商标注册申请
加载更多
公司概况
公司名称:
四川合纵药易购医药股份有限公司
所属行业:
批发业
上市日期:
2021-01-27
主营业务:
四川合纵药易购医药股份有限公司的主营业务是全渠道医药流通服务。公司的主要产品是化药、中药、医疗器械、大健康食品、其他非药产品。公司被四川省商务厅、四川省发展和改革委员会、四川省市场监督管理局评为“四川新业态新模式创新企业”。针对药易购在数字产业化方面做出的贡献,公司被四川省企业联合会评为“四川数字经济100强”。
发行价格:
12.25
{"stockData":{"symbol":"300937","market":"SZ","secType":"STK","nameCN":"药易购","latestPrice":19.12,"timestamp":1782457413000,"preClose":19.85,"halted":0,"volume":1921100,"delay":0,"changeRate":-0.0368,"floatShares":64864200,"shares":95666700,"eps":-0.2066,"marketStatus":"已收盘","change":-0.73,"latestTime":"06-26 15:00:00","open":19.75,"high":19.96,"low":19.1,"amount":37173100,"amplitude":0.0433,"askPrice":19.12,"askSize":46,"bidPrice":19.11,"bidSize":15,"shortable":0,"etf":0,"ttmEps":-0.2066,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782696600000},"marketStatusCode":5,"adr":0,"adjPreClose":19.85,"symbolType":"stock","openAndCloseTimeList":[[1782437400000,1782444600000],[1782450000000,1782457200000]],"highLimit":21.84,"lowLimit":17.87,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":95666682,"isCdr":false,"pbRate":2.32,"roa":"--","roe":"0.04%","epsLYR":-0.1343,"committee":0.201521,"marketValue":1829000000,"turnoverRate":0.0296,"status":1,"floatMarketCap":1240000000},"requestUrl":"/m/hq/s/300937","defaultTab":"news","newsList":[{"id":"2636016661","title":"股市必读:药易购(300937)5月15日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2636016661","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636016661?lang=zh_cn&edition=full","pubTime":"2026-05-18 03:49","pubTimestamp":1779047350,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,药易购报收于25.95元,下跌1.7%,换手率2.84%,成交量1.84万手,成交额4839.75万元。董秘最新回复投资者: 公司管理层如何看待公司股价市值持续低迷的情况?截止目前公司今年的经营发展及市场环境相较于去年有什么变化?公司治理层及管理层高度重视股价表现及市值管理,近期股价波动受宏观环境、行业情况及市场情绪等多重因素影响。当日关注点来自交易信息汇总:5月15日主力资金净流出586.69万元,显示主力短期减持动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800001572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","300937"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635261082","title":"药易购:公司不存在被实施其他风险警示(ST)的情形","url":"https://stock-news.laohu8.com/highlight/detail?id=2635261082","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635261082?lang=zh_cn&edition=full","pubTime":"2026-05-15 20:52","pubTimestamp":1778849523,"startTime":"0","endTime":"0","summary":"证券之星消息,药易购05月14日在投资者关系平台上答复投资者关心的问题。审计机构基于其独立判断出具保留意见,并不直接等同于上市公司财务报表存在错误或舞弊行为,主要是针对某些具体事项的审计范围或影响,而非对整个财务报表的真实性作出否定判断。前述情形结合相关规定来看,公司不存在被实施其他风险警示的情形。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500041130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300937","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635082481","title":"药易购:以全渠道供应链为核心,以数智创新技术为驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2635082481","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635082481?lang=zh_cn&edition=full","pubTime":"2026-05-15 20:48","pubTimestamp":1778849309,"startTime":"0","endTime":"0","summary":"证券之星消息,药易购05月15日在投资者关系平台上答复投资者关心的问题。公司始终致力于提升内在价值和长期竞争力,夯实公司可持续发展实力,为市值管理提供良好基础,维护广大投资者的利益;其中,战略定位层面,公司以全渠道供应链为核心,以数智创新技术为驱动,通过人才与资本加速发展;内部管理层面,公司设置有业绩与市值增长专岗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500040971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300937","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610634104","title":"药易购:公司始终将合规运营放在首位","url":"https://stock-news.laohu8.com/highlight/detail?id=2610634104","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610634104?lang=zh_cn&edition=full","pubTime":"2026-02-09 19:04","pubTimestamp":1770635040,"startTime":"0","endTime":"0","summary":"登录新浪财经APP 搜索【信披】查看更多考评等级\n证券日报网讯 2月9日,药易购在互动平台回答投资者提问时表示,公司始终将合规运营放在首位,持续优化治理结构,强化内部控制和合规管理,督促董高忠实、勤勉履职,从根本上保护投资者利益,致力于为股东创造长期、稳定的价值回报。关于公司后续是否投保董高责任险,将结合该险种的保险内容情况以及市场概况考虑,并严格按照法律法规相关规定履行相关信息披露义务。(文章来源:证券日报)\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-02-09/doc-inhmfqcf9128626.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-02-09/doc-inhmfqcf9128626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300937","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609567371","title":"药易购再向优秀员工授出7台阿维塔汽车 强化人才激励共谋长远发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2609567371","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609567371?lang=zh_cn&edition=full","pubTime":"2026-02-06 18:02","pubTimestamp":1770372120,"startTime":"0","endTime":"0","summary":"公司再度向在业务深耕、新业务拓展及多元生态构建中表现突出的优秀员工发放了7台阿维塔汽车,以激励人才,共谋发展。这是药易购继上市三周年相关激励后,又一次重要的人才激励举措。药易购始终将人才培养与团队建设置于重要位置,持续推出多元激励举措。未来,药易购将继续秉持“企业与员工共成长、共分享”的理念,推动员工成长与企业发展的同频共振,以扎实行动书写医药产业互联网发展新篇章,为产业高质量发展贡献更大力量。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-02-06/doc-inhkwnkf5053615.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0250","300937"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607013427","title":"药易购2025年业绩预降超七成,受市场环境及所得税政策调整等多重因素影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2607013427","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607013427?lang=zh_cn&edition=full","pubTime":"2026-01-30 17:24","pubTimestamp":1769765047,"startTime":"0","endTime":"0","summary":"中访网数据 四川合纵药易购医药股份有限公司于2026年1月30日发布了2025年度业绩预告。公告显示,公司预计2025年度归属于上市公司股东的净利润为280万元至420万元,较上年同期的1,635.82万元大幅下降74.32%至82.88%;扣除非经常性损益后的净利润预计为160万元至240万元,同比下降80.60%至87.07%。 本次业绩预告数据为公司财务部门初步测算结果,未经会计师事务所审计,具体财务数据将在公司2025年年度报告中正式披露。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260130/31987036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300937","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606227118","title":"药易购:公司将依据案件执行情况按会计准则进行会计处理","url":"https://stock-news.laohu8.com/highlight/detail?id=2606227118","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606227118?lang=zh_cn&edition=full","pubTime":"2026-01-27 11:34","pubTimestamp":1769484852,"startTime":"0","endTime":"0","summary":"证券之星消息,药易购01月26日在投资者关系平台上答复投资者关心的问题。关于公司诉讼收到执行款项的相关影响,公司将依据案件的执行情况对应的有关会计准则的要求进行相应的会计处理,最终会计处理及对公司本期利润或期后利润的影响数据将以审计机构年度审计确认后的结果为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700016224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300937","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603995172","title":"药易购:设立全资子公司赋能AI医疗全场景","url":"https://stock-news.laohu8.com/highlight/detail?id=2603995172","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603995172?lang=zh_cn&edition=full","pubTime":"2026-01-16 20:52","pubTimestamp":1768567922,"startTime":"0","endTime":"0","summary":"证券之星消息,药易购(300937)01月15日在投资者关系平台上答复投资者关心的问题。投资者提问:公司目前短期已布局AI医疗,是否在中长期在AI医疗方面会加大布局力度?药易购回复:您好!公司积极拥抱“医药+人工智能”核心战略,设立了全资子公司四川蜀坦人工智能科技有限公司,赋能AI创新药研发、AI慢病管理、AI诊疗机器人、AI穿戴设备等产业链全场景。未来,公司将持续投入资源,推进人工智能对业务的全方位赋能,提升生态协同价值。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600038752.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","159891","300937"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603982792","title":"股市必读:药易购(300937)1月15日收盘跌11.79%,主力净流入397.58万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603982792","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603982792?lang=zh_cn&edition=full","pubTime":"2026-01-16 01:17","pubTimestamp":1768497427,"startTime":"0","endTime":"0","summary":"截至2026年1月15日收盘,药易购报收于37.4元,下跌11.79%,换手率19.3%,成交量12.14万手,成交额4.65亿元。当日关注点来自交易信息汇总:药易购1月15日收盘报37.4元,跌11.79%,主力资金当日净流出3861.92万元。来自交易信息汇总:前10个交易日主力资金累计净流入1653.57万元,融资余额累计增加1701.4万元。资金流向1月15日主力资金净流出3861.92万元;游资资金净流出1636.28万元;散户资金净流入5498.2万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600000595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","300937"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603260705","title":"药易购:设立蜀坦人工智能并完成DeepSeek本地化部署","url":"https://stock-news.laohu8.com/highlight/detail?id=2603260705","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603260705?lang=zh_cn&edition=full","pubTime":"2026-01-15 20:52","pubTimestamp":1768481563,"startTime":"0","endTime":"0","summary":"证券之星消息,药易购01月14日在投资者关系平台上答复投资者关心的问题。公司始终重视人工智能等前沿技术对主营业务的赋能,在人工智能与数据技术方面,设立了子公司蜀坦人工智能以强化数字化生态,并完成了DeepSeek的本地化部署,积极推动内部数智化转型与外部生态赋能。这些举措旨在提升产业链效率、赋能上下游合作伙伴,从而提升公司的长期竞争力。相关重大信息请以公司公告为准,感谢您的关注!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500038847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161631","300937"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602552714","title":"股市必读:药易购(300937)1月9日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2602552714","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602552714?lang=zh_cn&edition=full","pubTime":"2026-01-12 01:50","pubTimestamp":1768153822,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘,药易购报收于36.75元,上涨3.87%,换手率17.36%,成交量10.92万手,成交额4.0亿元。董秘最新回复投资者: 请问贵公司截至2026年1月6号股东人数?您可参考公司定期报告中披露的股东人数情况;如临时查询股东人数,可向公司提供股东持股证明以及个人身份证件等相关资料后,查询对应信息。感谢您的理解与支持。交易信息汇总资金流向1月9日主力资金净流入1224.24万元;游资资金净流入1189.93万元;散户资金净流出2414.16万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200000787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300937","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595127727","title":"流感疫情持续,防控系统工程再受考验","url":"https://stock-news.laohu8.com/highlight/detail?id=2595127727","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595127727?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:18","pubTimestamp":1767172695,"startTime":"0","endTime":"0","summary":"2025年末,全国流感疫情持续处于高流行水平。产业链协同响应,构建多层次供应保障流感防控是一项系统工程,需要疫苗预防、快速诊断、药物治疗等多个环节的有效衔接。本轮疫情中,上市药企正通过全产业链布局,搭建从源头预防到终端治疗的健康保障网络。中成药在本轮疫情中表现活跃。公司表示,金振口服液四季度市场需求回暖,正加紧排产满足市场需要。随着该产品儿童流感新适应症的获批,其在儿科领域的应用场景进一步拓宽。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025123100030908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0010","603882","300937","000756","BK0188","BK0236","BK0086","002317","BK0196","300244","688276","BK0046","BK0074","BK0187","BK0183","000623","BK0250","BK0042","BK0284","BK0070","600079","603858","002728","BK0097","BK0077","BK0114","000999","301207","BK0060","BK0186","BK0185","BK0197","SG9999001069.SGD","BK0239","002393","600566","BK0164","BK0175","600557","BK0012","BK0028","BK0146","002603","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514366837","title":"药易购:公司已将符合条件的数据产品识别为无形资产并进行初始计量","url":"https://stock-news.laohu8.com/highlight/detail?id=2514366837","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514366837?lang=zh_cn&edition=full","pubTime":"2025-02-28 09:30","pubTimestamp":1740706230,"startTime":"0","endTime":"0","summary":"证券之星消息,药易购02月27日在投资者关系平台上答复投资者关心的问题。未来公司的数据资源会带来更多的价值吗?根据《企业数据资源相关会计处理暂行规定》,公司已将符合条件的数据产品识别为无形资产,并按照成本于“无形资产-数据资源”进行初始计量。相关数据请关注公司后续披露的定期报告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022800009222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","300937"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510784932","title":"医药商业板块盘中走弱,药易购领跌6.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510784932","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510784932?lang=zh_cn&edition=full","pubTime":"2025-02-11 09:50","pubTimestamp":1739238616,"startTime":"0","endTime":"0","summary":"2月11日,医药商业板块盘中下跌1.5%,药易购领跌6.61%,漱玉平民、开开实业跌超3%,健之佳、大参林跌超2%。板块实时资金流向显示,今日超大单净流出4008.74万元,今日小单净流入8519.08万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/11095048068133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300937","BK1161","BK1515","09939","BK0250","BK1574","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510006895","title":"异动快报:药易购(300937)2月10日11点11分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2510006895","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510006895?lang=zh_cn&edition=full","pubTime":"2025-02-10 11:15","pubTimestamp":1739157325,"startTime":"0","endTime":"0","summary":"证券之星2月10日盘中消息,11点11分药易购触及涨停板。目前价格32.22,上涨20.0%。其所属行业医药商业目前上涨。该股为互联网医疗,医药商业,医药概念热股,当日互联网医疗概念上涨4.33%,医药商业概念上涨2.39%,医药概念上涨1.76%。2月7日的资金流向数据方面,主力资金净流入828.46万元,占总成交额4.85%,游资资金净流入793.67万元,占总成交额4.64%,散户资金净流出1622.12万元,占总成交额9.49%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021000008588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300937","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507985612","title":"合纵药易购申请基于商品装箱的智能控制方法专利,便于引入可推荐商品并符合用户购买习惯","url":"https://stock-news.laohu8.com/highlight/detail?id=2507985612","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507985612?lang=zh_cn&edition=full","pubTime":"2025-01-31 09:42","pubTimestamp":1738287724,"startTime":"0","endTime":"0","summary":"金融界2025年1月31日消息,国家知识产权局信息显示,四川合纵药易购医药股份有限公司申请一项名为“一种基于商品装箱的智能控制方法”的专利,公开号CN 119378861 A,申请日期为2024年10月。通过天眼查大数据分析,四川合纵药易购医药股份有限公司共对外投资了24家企业,参与招投标项目28次,知识产权方面有商标信息150条,专利信息13条,此外企业还拥有行政许可31个。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/31094247912801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300937","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504240733","title":"药易购(300937.SZ)发预减,预计年度净利润1450万元-1950万元,同比下降67.24%-75.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504240733","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504240733?lang=zh_cn&edition=full","pubTime":"2025-01-20 20:58","pubTimestamp":1737377933,"startTime":"0","endTime":"0","summary":"智通财经APP讯,药易购(300937.SZ)披露2024年度业绩预告,公司预计归属于上市公司股东的净利润1450万元-1950万元,同比下降67.24%-75.64%;扣除非经常性损益后的净利润875万元-1275万元,同比下降76.40%-83.81%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1240705.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300937"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504016214","title":"药易购:预计2024年全年归属净利润盈利1450万元至1950万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504016214","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504016214?lang=zh_cn&edition=full","pubTime":"2025-01-20 20:04","pubTimestamp":1737374647,"startTime":"0","endTime":"0","summary":"证券之星消息,药易购发布业绩预告,预计2024年全年归属净利润盈利1450万元至1950万元。药易购2024年三季报显示,公司主营收入32.35亿元,同比上升0.72%;归母净利润1393.15万元,同比下降72.22%;扣非净利润936.53万元,同比下降80.09%;其中2024年第三季度,公司单季度主营收入10.1亿元,同比上升0.26%;单季度归母净利润183.57万元,同比下降46.63%;单季度扣非净利润88.41万元,同比下降69.25%;负债率50.1%,投资收益-46.81万元,财务费用657.8万元,毛利率8.61%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012000030653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300937"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502845013","title":"药易购新提交2件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2502845013","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502845013?lang=zh_cn&edition=full","pubTime":"2025-01-12 05:06","pubTimestamp":1736629590,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,近日四川合纵药易购医药股份有限公司新提交2件商标注册申请。商标申请详情如下:今年以来四川合纵药易购医药股份有限公司新申请注册商标0件,截止目前公司共持有注册商标239件,另有76件商标尚在注册申请中。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011200000104.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","300937"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782573293011,"stockEarnings":[{"period":"1week","weight":-0.0723},{"period":"1month","weight":-0.1723},{"period":"3month","weight":-0.3543},{"period":"6month","weight":-0.455},{"period":"1year","weight":-0.3072},{"period":"ytd","weight":-0.4391}],"compareEarnings":[{"period":"1week","weight":-0.0155},{"period":"1month","weight":-0.0162},{"period":"3month","weight":0.029},{"period":"6month","weight":0.016},{"period":"1year","weight":0.1678},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"四川合纵药易购医药股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"14259人(较上一季度减少19.80%)","perCapita":"4548股","listingDate":"2021-01-27","address":"四川省成都市金牛区友联一街18号13层","registeredCapital":"9566万元","survey":" 四川合纵药易购医药股份有限公司的主营业务是全渠道医药流通服务。公司的主要产品是化药、中药、医疗器械、大健康食品、其他非药产品。公司被四川省商务厅、四川省发展和改革委员会、四川省市场监督管理局评为“四川新业态新模式创新企业”。针对药易购在数字产业化方面做出的贡献,公司被四川省企业联合会评为“四川数字经济100强”。","listedPrice":12.25},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药易购(300937)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药易购(300937)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药易购,300937,药易购股票,药易购股票老虎,药易购股票老虎国际,药易购行情,药易购股票行情,药易购股价,药易购股市,药易购股票价格,药易购股票交易,药易购股票购买,药易购股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药易购(300937)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药易购(300937)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}